BrightOcular® Cosmetic Iris Implant: A Spectrum from Tolerability to Severe Morbidity
| dc.contributor.author | Koaik, Mona K. | |
| dc.contributor.author | Mansour, Ahmad Mohammed Farid Mahmoud | |
| dc.contributor.author | Saad, Alain | |
| dc.contributor.author | Farah, Samir G. | |
| dc.contributor.department | Ophthalmology | |
| dc.contributor.faculty | Faculty of Medicine (FM) | |
| dc.contributor.institution | American University of Beirut | |
| dc.date.accessioned | 2025-01-24T12:08:36Z | |
| dc.date.available | 2025-01-24T12:08:36Z | |
| dc.date.issued | 2018 | |
| dc.description.abstract | Purpose: The BrightOcular® implants are the newest model of cosmetic iris devices that are currently advertised as safe. The previous generation known as NewColorIris® have had severe ocular side effects and were subsequently withdrawn from the market. There is little literature on the safety profile of BrightOcular® implants. Case Report: Herein we describe two cases with varying degrees of ocular tolerability. The first case had a normal ocular exam 1 year after implantation, whereas the second case had unilateral severe corneal edema requiring explantation of the iris device and Descemet membrane endothelial keratoplasty 9 months after bilateral implantation. Conclusions: These two cases attest to the unpredictability of the results of these cosmetic surgeries. Patients should be counseled about the vision-threatening complications of iris implants. © 2018 The Author(s). | |
| dc.identifier.doi | https://doi.org/10.1159/000492745 | |
| dc.identifier.eid | 2-s2.0-85052949133 | |
| dc.identifier.uri | http://hdl.handle.net/10938/31857 | |
| dc.language.iso | en | |
| dc.publisher | S. Karger AG | |
| dc.relation.ispartof | Case Reports in Ophthalmology | |
| dc.source | Scopus | |
| dc.subject | Brightocular® iris implant | |
| dc.subject | Cosmetic iris implants | |
| dc.subject | Safety | |
| dc.subject | Tolerability | |
| dc.subject | Dexamethasone | |
| dc.subject | Tobramycin | |
| dc.subject | Adult | |
| dc.subject | Anterior eye chamber depth | |
| dc.subject | Anterior eye segment | |
| dc.subject | Article | |
| dc.subject | Best corrected visual acuity | |
| dc.subject | Blurred vision | |
| dc.subject | Case report | |
| dc.subject | Caucasian | |
| dc.subject | Cell density | |
| dc.subject | Central corneal thickness | |
| dc.subject | Clinical article | |
| dc.subject | Cornea edema | |
| dc.subject | Corneal pachymetry | |
| dc.subject | Descemet membrane endothelial keratoplasty | |
| dc.subject | Disease duration | |
| dc.subject | Disease severity | |
| dc.subject | Endothelium cell | |
| dc.subject | Esthetic surgery | |
| dc.subject | Eye refraction | |
| dc.subject | Female | |
| dc.subject | Follow up | |
| dc.subject | Gonioscopy | |
| dc.subject | Human | |
| dc.subject | India | |
| dc.subject | Intraocular pressure | |
| dc.subject | Keratomileusis | |
| dc.subject | Morbidity | |
| dc.subject | Myopia | |
| dc.subject | Open angle glaucoma | |
| dc.subject | Ophthalmoscopy | |
| dc.subject | Optical coherence tomography | |
| dc.subject | Patient safety | |
| dc.subject | Priority journal | |
| dc.subject | Retinal nerve fiber layer thickness | |
| dc.subject | Slit lamp microscopy | |
| dc.subject | Surgical technique | |
| dc.subject | Visual acuity | |
| dc.subject | Visual field | |
| dc.subject | Vitreous floaters | |
| dc.title | BrightOcular® Cosmetic Iris Implant: A Spectrum from Tolerability to Severe Morbidity | |
| dc.type | Article |
Files
Original bundle
1 - 1 of 1